Oral May Actually Work Better Clinical trials showed oral Wegovy (25mg maintenance) achieved up to 16.6% weight loss vs 14.9% for the injectionwhile being significantly cheaper without insurance
Mast cell activation and histamine intolerance overlap with oxalate sensitivity in a couple of ways: A study involving cell samples from patients with kidney stones found that they had higher mast cell counts than a healthy control group.[ref] Ketotifen, a drug that stops mast cell degranulation, reduces the formation of calcium oxalate kidney stones.[ref] Interestingly, the reason that stinging nettles cause severe skin irritation is that they contain oxalic acid and tartaric acid, which have been shown to activate mast cells.[ref][ref] Related article : Mast cell activation syndrome and Histamine intolerance Inflammation: Macrophage activation by oxalate crystals Macrophages are a type of white blood cell that can exist in an anti-inflammatory state (M2) that promotes healing or in a pro-inflammatory state (M1) that increases ROS and inflammation
This mirrors the maintenance dosing strategy being explored with tirzepatide and other medications
To view digital features for this article go to Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of incretin-based therapies for the treatment of type 2 diabetes (T2D), have been shown to be highly effective for both glycaemic control and weight loss, and are associated with a low risk of hypoglycaemia [1]
It has already been prescribed for several years and used by diabetes patients as an injectable medicine used for the management of diabetes by improving glycemic control
